CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- 4 Shares withheld for taxes Chief Financial Officer gave up 703 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale President sold 53,336 shares at $51.37 ($2,739,870)
- 4 Planned sale Chief Legal Officer sold 3,471 shares at $50.00 ($173,550)
- 4 Shares withheld for taxes Chief Financial Officer gave up 5,705 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,197 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 1,047 shares (to pay taxes)
- 4 Shares withheld for taxes President gave up 4,488 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 533 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 533 shares (to pay taxes)
- 4 Shares withheld for taxes President gave up 990 shares (to pay taxes)
- 4 Open-market sale Director sold 9,263 shares at $46.84 ($433,879)
- 4 Planned sale President sold 53,336 shares at $48.40 ($2,581,462)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 54 · 1,067 filings